22 May 2013
Keywords: amgen, issue, 4b, senior, notes, faces, law
Article | 28 May 2007
US biotechnology major Amgen says that it intends to offer around $4.0 billion in securities. The offer, which is subject to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.